PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 8865525-0 1996 Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII. Gemfibrozil 0-11 coagulation factor II, thrombin Homo sapiens 20-28 8865525-7 1996 Thus, gemfibrozil reduced thrombin generation in men with combined hyperlipoproteinaemia, without influencing the plasma levels of fibrinogen, VIIa and XIIa, or fibrin gel structure. Gemfibrozil 6-17 coagulation factor II, thrombin Homo sapiens 26-34 8865525-8 1996 Attenuation of thrombin generation may contribute to the primary-preventive effects of gemfibrozil on coronary heart disease. Gemfibrozil 87-98 coagulation factor II, thrombin Homo sapiens 15-23 1519208-4 1992 Plasma prothrombin fragment F1 + 2 concentration, a marker of the in vivo rate of generation of thrombin, was 25 (12 to 37)% lower on average while on gemfibrozil than during the placebo phase. Gemfibrozil 151-162 coagulation factor II, thrombin Homo sapiens 10-18